why choose us

First received: October 11, 2024

Clinical Trial: A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hematopoietic and Lymphatic System Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer

Brief Summary: This phase I trial tests the safety and side effects of a second episode of psilocybin-assisted group therapy and how well it works in treating anxiety and distress in patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) and had a partial response to their first retreat.Up to 50% of patients with metastatic cancer have clinically significant anxiety and unaddressed anxiety and distress may add to the suffering caused by cancer itself.Psilocybin, a…

Read more